QA: Adial Pharmaceuticals INC in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001513525_2021_Adial_Pharmaceuticals_INC.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001513525, Adial Pharmaceuticals INC

  xvar xval
0 AssetsCurrent 5,135,838
1 IntangibleAssetsNetIncludingGoodwill 5,606
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 350,000
4 LiabilitiesCurrent 1,505,378
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 5,074,694
9 ResearchAndDevelopmentExpense 5,853,291
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 34,995
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 5,491,444
1 Liabilities 1,505,378
2 Expenses 10,927,985
3 Revenues 0
4 StockholdersEquity 3,986,066
5 NetIncome -10,892,990
6 ComprehensiveNetIncome -10,892,990
7 BaseVar 8,979,901
8 EconomicCapitalRatiobeforeLimitedLiability -0.630
9 EconomicCapitalRatio 1.37

Edgar->Model Mapping

Feature Distribution

Change over Time